D-0517-2017 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- March 22, 2017
- Initiation Date
- February 7, 2017
- Termination Date
- February 16, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7,628 HDPE bottles (228,840 tablets)
Product Description
Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30 count HDPE bottles, Rx Only, Distributed by TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0093-5721-56
Reason for Recall
Failed Impurities/Degradation Specifications
Distribution Pattern
Nationwide
Code Information
Lot 30227056A; Exp. 03/17